Niagen Bioscience (NAGE) Times Interest Earned (2010 - 2022)
Niagen Bioscience (NAGE) reported Times Interest Earned of -$613.0 for Q3 2022, down 4.0% year-over-year from -$638.57 in Q3 2021, and up 4.02% quarter-over-quarter from -$638.7 in Q2 2022.
Niagen Bioscience (NAGE) Times Interest Earned (2010 - 2022) Analysis & Trends
Niagen Bioscience (NAGE) has 13 years of Times Interest Earned data on file, last reported at -$613.0 in Q3 2022.
- Times Interest Earned for Q3 2022 came in at -$613.0, down 4.0% year-over-year; the trailing twelve-month figure through Jun 2023 was -$1758.6 (down 161.22% YoY), and the FY2021 annual result was -$492.24, down 76.03% from the prior year.
- Times Interest Earned advanced to -$613.0 in Q3 2022 per NAGE's latest filing, from -$638.7 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$12.49 in Q2 2019 and troughed at -$966.5 in Q1 2022.
- A 5-year average of -$420.38 and a median of -$387.47 in 2021 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2018 and 2019: Times Interest Earned plunged 1253.27% in 2018, then soared 97.7% in 2019.
- A 5-year view of Times Interest Earned shows it stood at -$955.11 in 2018, then surged by 97.7% to -$21.94 in 2019, then plunged by 1632.57% to -$380.06 in 2020, then slumped by 55.41% to -$590.67 in 2021, then decreased by 3.78% to -$613.0 in 2022.
- Business Quant data shows NAGE's Times Interest Earned at -$613.0 in Q3 2022, -$638.7 in Q2 2022, and -$966.5 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -613.00 |
| Jun 30, 2022 | -638.70 |
| Mar 31, 2022 | -966.50 |
| Dec 31, 2021 | -590.67 |
| Sep 30, 2021 | -589.40 |
| Jun 30, 2021 | -462.83 |
| Mar 31, 2021 | -387.47 |
| Dec 31, 2020 | -380.06 |
| Sep 30, 2020 | -220.84 |
| Jun 30, 2020 | -153.63 |
| Sep 30, 2019 | -21.94 |
| Jun 30, 2019 | -12.49 |
| Sep 30, 2018 | -955.11 |
| Jun 30, 2018 | -122.11 |
| Mar 31, 2018 | -190.89 |
| Dec 30, 2017 | -199.50 |
| Sep 30, 2017 | -70.58 |
| Jul 1, 2017 | -73.61 |
| Apr 1, 2017 | -63.32 |
| Dec 31, 2016 | -118.30 |